Product image of Zolestad (Zoledronic Acid) supplied by GNH India

Zolestad

Active Ingredient:
Zoledronic Acid
Origin:
EU

Zolestad (Zoledronic Acid)

Zolestad (Zoledronic Acid) is an intravenous bisphosphonate used to support bone health and reduce bone-related complications. This medication helps manage conditions linked to bone metabolism. Always consult a healthcare professional for personalized guidance.

Manufacturer / TM Owner

Stada Arzneimittel Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Zolestad (Zoledronic Acid) is commonly used to treat conditions related to bone strength and turnover, such as osteoporosis and bone metastases. It may also be prescribed to reduce high calcium levels in the blood caused by certain cancers. Patients often ask, 'what is Zoledronic Acid used for' to understand its role in bone health management.

Side Effects

  • Zolestad (Zoledronic Acid) works by slowing bone breakdown and promoting bone density. Many users notice improved bone stability over time. Some may experience mild effects like fatigue or flu-like symptoms after administration.

Precautions & Warnings

  • Zolestad (Zoledronic Acid) should be administered under medical supervision due to its potent effects on bone metabolism. Patients with kidney issues or low calcium levels should discuss risks with their doctor. Hydration and regular monitoring are often recommended during treatment.

Avoid Interactions

  • Zolestad (Zoledronic Acid) may interact with other medications affecting bone health, such as calcium supplements or certain diuretics. Combining it with nephrotoxic drugs could require dose adjustments. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Zoledronic Acid is primarily used to treat osteoporosis and bone metastases. It helps reduce bone loss and complications from cancer that affects bones.

Zolestad is given as an intravenous infusion by a healthcare professional. The process typically takes 15 minutes or longer, depending on the prescribed dose.

Some users may experience flu-like symptoms or fatigue after treatment. Rarely, it can affect kidney function, so monitoring is advised.

Patients with severe kidney disease or low blood calcium should avoid Zolestad unless directed by a doctor. Pregnant or breastfeeding individuals should consult a healthcare provider.

Zolestad helps manage osteoporosis by slowing bone loss but is not a cure. It should be part of a broader treatment plan including diet and exercise.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Zoledronic Acid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT